Promis Neurosciences Inc Share Price (NASDAQ: PMN)

Promis Neurosciences Inc Stock Performance

as on October 16, 2025 at 12:38 am IST

Day's Low
Day's High
$0.46
Day's Price Range
$0.5
$0.48
4.17%
Downside
4.17%
Upside
52 Week's Low
52 Week's High
$0.38
52-Week Price Range
$1.59
$0.48
20.83%
Downside
231.25%
Upside

Promis Neurosciences Inc share price movements today

Previous Close: $0.46
Open: $0.48
Volume: 1.4M
Day's Low - High: $0.46 - $0.5
52 Week Low - High: $0.38 - $1.59

Promis Neurosciences Inc Historical Returns

1 Month Return: + 9.7 %
3 Month Return: + 4.32 %
1 Year Return: -54.97 %
3 Year Return: -92.29 %
5 Year Return: 0 %

Promis Neurosciences Inc Stock Fundamentals & Key Indicators

Check Promis Neurosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$25.8M

EPS (TTM)

-1.4265

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-13.3M

Revenue (TTM)

7.6K

Profit Margin

0.00%

Return On Equity TTM

0.00%

Promis Neurosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Promis Neurosciences Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Promis Neurosciences Inc	BUY	$25.8M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.9B	226.08%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.1B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$104.4B	91.48%	28.99	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.1B	-2.15%	14.07	31.37%

Stock Returns calculator for Promis Neurosciences Inc Stock including INR - Dollar returns

The Promis Neurosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Promis Neurosciences Inc investment value today

Current value as on today

₹51,890

Returns

₹48,110

(-48.11%)

Returns from Promis Neurosciences Inc Stock

₹52,941 (-52.94%)

Dollar Returns*

₹4,831 (+4.83%)

Analyst Recommendation on Promis Neurosciences Inc Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Promis Neurosciences Inc. Average target price of $5.49

Promis Neurosciences Inc Share Price Target

Get share price movements and forecasts by analysts on Promis Neurosciences Inc.

What analysts predicted

91.26%UPSIDE

Target Price

$5.49

Current Price

$0.48

Analyzed by

6 Analysts

Target

$5.49

Promis Neurosciences Inc target price $5.49, a slight upside of 91.26% compared to current price of $0.48. According to 6 analysts rating.

Promis Neurosciences Inc Stock’s Investor Sentiment and Interest

Search interest for Promis Neurosciences Inc Stock has increased by 294% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 16, 2025 to October 16, 2025

Change:294% versus previous 30 day period

Promis Neurosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	-	-	-	0	-	-	-	-	-
Gross Profit	0	0	0	-	0	-	-	-	-	-
Operating Income	-4	-2	-2	-3	-3	-2	-4	-6	-7	-10
EBITDA	-4	-2	-2	-	-3	-2	9	0	-7	-10
Interest Expense	0	0	0	0	0	-	-	76	-	-
Depreciation	0	0	0	0	-	-	-	-	-	-
Income Before Tax	-4	-2	-2	-3	-3	-2	9	0	-7	-10
Income Tax Expense	0	0	0	-	0	-	-	-	-	-
Net Income	-3	-1	-1	-3	-3	-2	9	0	-7	-10
Net Profit Margin	118854.17%	0.00%	0.00%	0.00%	-57928.29%	0.00%	0.00%	0.00%	0.00%	0.00%

Promis Neurosciences Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	0	0	0	0	0	-	-
Gross Profit	0	0	0	0	-3	-2	-4	-16	-10	-
Operating Income	-1	-2	-4	-7	-5	-4	-8	-23	-18	-16,827
EBITDA	-1	-2	-4	-7	-5	-4	-9	-29	-17	-16,827
Interest Expense	0	0	0	-	-	-	0	0	0	0
Depreciation	-	-	-	0	0	0	0	0	0	-
Income Before Tax	-1	-2	-4	-7	-5	-4	-9	-18	-17	2
Income Tax Expense	0	0	0	0	-	-	0	-5	0	-
Net Income	-1	-1	-3	-5	-4	-3	-7	-9	-17	2,778
Net Profit Margin	-10639.79%	-128390.21%	-60838.48%	-2140457.07%	-615327.56%	-316866.43%	-118662.18%	-156592.75%	0.00%	0.00%

Promis Neurosciences Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	-2	-4	-3	-2	9	0	-7	-10
Operating Cash Flow	-2	-2	-	-10	-1	-6	-8	-4	-3
Investing Cash Flow	-	0	-	0	-	-	0	-	-
Financing Cash Flow	-	18	-	0	0	27	0	-	-
Change in Cash	-2	15	-	-10	-1	20	-8	-4	-3

Promis Neurosciences Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-4	-7	-5	-4	-9	-18	-17	2
Operating Cash Flow	-1	-4	-6	-4	-3	-9	-17	-14	-27
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	1	5	6	4	3	25	6	23	27
Change in Cash	0	0	0	0	0	16	-11	8	0

Global Institutional Holdings in Promis Neurosciences Inc

Funds	Holdings
Great Point Partners LLC	5.11%
Armistice Capital, LLC	4.13%
Sphera Funds Management Ltd.	3.67%
Ally Bridge Group (NY) LLC	2.58%
Altium Capital Management, LP	1.11%

See all

Insights on Promis Neurosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.0% return, outperforming this stock by 245.3%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 118.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, PMN stock has moved down by -19.4%

About Promis Neurosciences Inc

promis™ neurosciences, inc. (tse: pmn, https://ca.finance.yahoo.com/q/bc?s=pmn.to), is a development stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular alzheimer’s disease (ad) and amyotrophic lateral sclerosis (als). the company’s scientific foundation centers on the growing knowledge base relating to diseases characterized by the presence of abnormal, misfolded proteins. several neurodegenerative diseases exhibit protein misfolding, such as ad, als, and parkinson’s disease (pd). recent published evidence indicates that for a given misfolded protein there exist multiple prion-like strains, each strain representing a specific target against which specific therapeutics can be developed. the company is focused on the discovery and development of precision therapeutics and companion diagnostics to combat the several strains of beta-amyloid (aβ) and tau i

Organisation	Promis Neurosciences Inc
Headquarters	1920 Yonge Street, Toronto, ON, Canada, M4S 3E2
CEO	Mr. Neil K. Warma M.B.A.
E-voting on shares	Click here to vote

Key Management of Promis Neurosciences Inc

Name	Title
Mr. Eugene W. Williams	Co-Founder & Chairman
Mr. Neil K. Warma M.B.A.	CEO, President, Compliance Officer & Director
Dr. Neil R. Cashman M.D.	Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
Mr. Daniel E. Geffken M.B.A.	Chief Financial Officer
Dr. Johanne Kaplan Ph.D.	Chief Development Officer
Dr. David Wishart Ph.D.	Chief Physics Officer
Mr. Dennis Chen Ph.D.	Head of Manufacturing & Senior Consultant
Dr. Larry Douglas Altstiel M.D., Ph.D.	Chief Medical Officer

FAQs

What is Promis Neurosciences Inc share price today?

Promis Neurosciences Inc share price today is $0.48 as on October 16, 2025 at 12:38 am IST. Promis Neurosciences Inc share today touched a day high of $0.5 and a low of $0.46.

What is the 52 week high and 52 week low for Promis Neurosciences Inc share?

Promis Neurosciences Inc share touched a 52 week high of $1.59 on July 21, 2025 and a 52 week low of $0.38 on July 8, 2025. Promis Neurosciences Inc stock price today i.e. October 16, 2025 at 12:38 am IST is trending at $0.48,which is 69.81% down from its 52 week high and 26.32% up from its 52 week low.

What is Promis Neurosciences Inc's market capitalisation today?

Promis Neurosciences Inc market capitalisation is $0.00T as on October 16, 2025 at 12:38 am IST.

How to invest in Promis Neurosciences Inc Stock (PMN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Promis Neurosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Promis Neurosciences Inc Shares that will get you 3.1250 shares as per Promis Neurosciences Inc share price of $0.48 per share as on October 16, 2025 at 12:38 am IST.

What is the minimum amount required to buy Promis Neurosciences Inc Stock (PMN) from India?

Indian investors can start investing in Promis Neurosciences Inc (PMN) shares with as little as ₹87.985 or $1 (as of October 16, 2025 at 12:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Promis Neurosciences Inc stock (as per the Rupee-Dollar exchange rate as on October 16, 2025 at 12:41 am IST). Based on Promis Neurosciences Inc share’s latest price of $0.48 as on October 16, 2025 at 12:38 am IST, you will get 20.8333 shares of Promis Neurosciences Inc. Learn more about fractional shares .